Corient Private Wealth’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,451
Closed -$310K 2508
2024
Q3
$310K Buy
12,451
+5,369
+76% +$159K ﹤0.01% 1994
2024
Q2
$210K Buy
+7,082
New +$196K ﹤0.01% 2103
2023
Q4
Sell
-6,198
Closed -$230K 2333
2023
Q3
$230K Sell
6,198
-125
-2% -$4.78K ﹤0.01% 1852
2023
Q2
$247K Sell
6,323
-1,927
-23% -$75.5K ﹤0.01% 1787
2023
Q1
$301K Buy
+8,250
New +$260K ﹤0.01% 1604

Other funds holding RTO

Corient Private Wealth's RTO Position: Q4 2024 in Review

Corient Private Wealth sold out of Rentokil (RTO) in Q4 2024, closing a stake of 12,451 shares — an estimated $310K sold.

Corient Private Wealth first reported a position in RTO in Q1 2023 and held it in 5 quarters. The position peaked at $310K in Q3 2024. 226 funds tracked by Wall St. Rank hold RTO as of Q4 2024.

  • Corient Private Wealth reported no remaining Rentokil position as of Q4 2024 after selling out during the quarter.
  • Corient Private Wealth sold 12,451 Rentokil shares in Q4 2024, an estimated $310K.
  • Corient Private Wealth first reported a position in Rentokil in Q1 2023 and held it in 5 quarters.
  • Corient Private Wealth's Rentokil position peaked at $310K in Q3 2024.
  • 226 funds tracked by Wall St. Rank held Rentokil as of Q4 2024.

Based on Corient Private Wealth's 13F filing for Q4 2024, filed 10 Feb 2025.